Safe and effective pool testing for SARS-CoV-2 detection.
Pool testing
SARS-CoV-2
Surveillance
Journal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
31
03
2021
revised:
01
08
2021
accepted:
19
10
2021
pubmed:
15
11
2021
medline:
15
12
2021
entrez:
14
11
2021
Statut:
ppublish
Résumé
The global spread of SARS-CoV-2 is a serious public health issue. Large-scale surveillance screenings are crucial but can exceed test capacities. We (A) optimized test conditions and (B) implemented pool testing of respiratory swabs into SARS-CoV-2 diagnostics. (A) We determined the optimal pooling strategy and pool size. In addition, we measured the impact of vortexing prior to sample processing, compared a pipette-pooling method (by combining transport medium of several specimens) and a swab-pooling method (by combining several swabs into a test tube filled with PBS) as well as determined the sensitivities of three PCR assays. (B) Finally, we applied high-throughput pool testing for diagnostics. (A) In a low prevalence setting, we defined a preferable pool size of ten in a two-stage hierarchical pool testing strategy. Vortexing of swabs (n = 33) increased cellular yield by a factor of 2.34. By comparing Ct-values of 16 pools generated with two different pooling strategies, pipette-pooling was more efficient compared to swab-pooling. Measuring dilution series of 20 SARS-CoV-2 positive samples in three PCR assays simultaneously revealed detection rates of 85% (assay I), 50% (assay II), and 95% (assay III) at a 1:100 dilution. (B) We systematically pooled 55,690 samples in a period of 44 weeks resulting in a reduction of 47,369 PCR reactions. For implementing pooling strategies into high-throughput diagnostics, we recommend utilizing a pipette-pooling method, performing sensitivity validation of the PCR assays used, and vortexing swabs prior to analyses. Pool testing for SARS-CoV-2 detection is feasible and effective in a low prevalence setting.
Identifiants
pubmed: 34775143
pii: S1386-6532(21)00285-7
doi: 10.1016/j.jcv.2021.105018
pmc: PMC8552800
pii:
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105018Informations de copyright
Copyright © 2021. Published by Elsevier B.V.
Références
J Clin Microbiol. 2012 Mar;50(3):891-6
pubmed: 22205820
Clin Infect Dis. 2021 Mar 15;72(6):1104-1105
pubmed: 32544948
Clin Infect Dis. 2021 Jul 15;73(2):321-323
pubmed: 32986122
Sci Transl Med. 2021 Apr 14;13(589):
pubmed: 33619080
PLoS One. 2021 Feb 8;16(2):e0246285
pubmed: 33556129
J Med Virol. 2021 Mar;93(3):1526-1531
pubmed: 32869865
Emerg Infect Dis. 2021 Apr;27(4):
pubmed: 33755009
PLoS One. 2021 Feb 26;16(2):e0247767
pubmed: 33635923
J Lab Physicians. 2020 Dec;12(3):212-218
pubmed: 33268939
Nucleic Acids Res. 2009 Apr;37(6):e45
pubmed: 19237396
Lancet Infect Dis. 2020 Nov;20(11):1233
pubmed: 32679083
Sci Adv. 2020 Sep 11;6(37):
pubmed: 32917716
Int J Cancer. 2002 Apr 1;98(4):590-5
pubmed: 11920620
Lancet Infect Dis. 2020 Nov;20(11):1233-1234
pubmed: 32679088
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
JAMA. 2020 May 19;323(19):1967-1969
pubmed: 32250394
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Microbiol Infect. 2020 Sep;26(9):1248-1253
pubmed: 32585353
Signif (Oxf). 2020 Jun;17(3):15-16
pubmed: 32536952
Lancet Infect Dis. 2020 Nov;20(11):1231-1232
pubmed: 32530425
Nat Biomed Eng. 2020 Dec;4(12):1123-1124
pubmed: 33293721
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet Infect Dis. 2020 Nov;20(11):1232-1233
pubmed: 32679080
J Clin Microbiol. 2006 Jun;44(6):2265-7
pubmed: 16757636
Science. 2020 Jul 10;369(6500):
pubmed: 32414780
Sci Rep. 2021 Feb 4;11(1):3122
pubmed: 33542424
Nat Med. 2020 May;26(5):643-644
pubmed: 32405055
Clin Infect Dis. 2020 Nov 19;71(16):2073-2078
pubmed: 32358960
J Virol Methods. 2008 Nov;153(2):84-9
pubmed: 18761378
Front Med (Lausanne). 2021 Feb 04;8:640688
pubmed: 33614689
J R Stat Soc Ser C Appl Stat. 2015 Aug 1;64(4):693-710
pubmed: 26166904